![](/img/cover-not-exists.png)
Rationale and design of a phase II study to evaluate prophylactic treatment of dacomitinib-induced dermatologic adverse events in epidermal growth factor receptor-mutated advanced non-small cell lung cancer (SPIRAL-Daco study)
Iwasaku, Masahiro, Uchino, Junji, Yamada, Tadaaki, Chihara, Yusuke, Shimamoto, Takayuki, Tamiya, Nobuyo, Kaneko, Yoshiko, Kiyomi, Fumiaki, Takayama, KoichiVolume:
8
Journal:
Translational Lung Cancer Research
DOI:
10.21037/tlcr.2019.08.03
Date:
August, 2019
File:
PDF, 193 KB
2019